{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:15:34Z","timestamp":1778890534801,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"27","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.vaccine.2019.05.012","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T17:21:28Z","timestamp":1558372888000},"page":"3580-3587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Complementary use of mass spectrometry and cryo-electron microscopy to assess the maturity of live attenuated dengue vaccine viruses"],"prefix":"10.1016","volume":"37","author":[{"given":"Mathieu","family":"Trauchessec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Bonnafous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Berard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabienne","family":"Barriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celine","family":"Huillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devika","family":"Sirohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Hedrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Ronzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Manin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.05.012_b0005","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4269\/ajtmh.2012.12-0157","article-title":"The economic burden of dengue","volume":"86","author":"Gubler","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2019.05.012_b0010","unstructured":"Organization WH Dengue: Guidelines for diagnosis, treatment, prevention and control; 2009."},{"issue":"496","key":"10.1016\/j.vaccine.2019.05.012_b0015","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"25","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.05.012_b0020","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1016\/j.vaccine.2015.09.108","article-title":"Development of the Sanofi Pasteur tetravalent dengue vaccine: one more step forward","volume":"33","author":"Guy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.012_b0025","article-title":"Efficacy of a tetravalent dengue vaccine in children in latin america","volume":"372","author":"Villar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.05.012_b0030","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.05.012_b0035","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.05.012_b0040","unstructured":"World Health Organization. Dengue and severe dengue. Fact sheet No. 117. s.l.: http:\/\/www.who.int\/mediacentre\/factsheets\/fs117\/en\/index.html."},{"key":"10.1016\/j.vaccine.2019.05.012_b0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.mib.2008.06.004","article-title":"Stuctural proteomics of dengue virus","volume":"11","author":"Perera","year":"2008","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0050","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Sciences (New York)"},{"key":"10.1016\/j.vaccine.2019.05.012_b0055","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/embor.2011.75","article-title":"Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres","volume":"12","author":"Plevka","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1016\/j.vaccine.2019.05.012_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coviro.2015.04.006","article-title":"Temperature dependent conformational change of dengue virus","volume":"12","author":"Zhang","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0065","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.1304300110","article-title":"Dengue structure differs at the temperatures of its human and mosquito hosts","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2019.05.012_b0070","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1099\/vir.0.2008\/002535-0","article-title":"Functional importance of dengue virus maturation: infectious properties of immature virions","volume":"89","author":"Zybert","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1335201","article-title":"A recombinant live attenuated tetravalent vaccine for the prevention of dengue","volume":"16","author":"Guy","year":"2017","journal-title":"Exp Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.05.012_b0080","article-title":"Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes","author":"Lecouturier","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.05.012_b0085","unstructured":"Kuhn RJ, Paige Riley C, Buck C. US 2013\/0059291 A1. US Pat Appl Publ; 2013."},{"key":"10.1016\/j.vaccine.2019.05.012_b0090","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1074\/mcp.M113.032672","article-title":"Mass spectrometry-based workflow for accurate quantification of escherichia coli enzymes: how proteomics can play a key role in metabolic engineering","volume":"13","author":"Trauchessec","year":"2014","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2019.05.012_b0095","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2009.05.051","article-title":"Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics","volume":"138","author":"Picotti","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2019.05.012_b0100","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/msb.2008.61","article-title":"Selected reaction monitoring for quantitative proteomics: a tutorial","volume":"4","author":"Lange","year":"2008","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0105","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1073\/pnas.0832254100","article-title":"Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS","volume":"100","author":"Gerber","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2019.05.012_b0110","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1002\/pmic.201500101","article-title":"Absolute quantification of dengue virus serotype 4 chimera vaccine candidate in Vero cell culture by targeted mass spectrometry","volume":"15","author":"Rougemont","year":"2015","journal-title":"Proteomics"},{"key":"10.1016\/j.vaccine.2019.05.012_b0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3. 5-\u00c5 resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat Struct Ans Mol Biol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0120","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1128\/JVI.00696-10","article-title":"Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles","volume":"84","author":"Junjhon","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0125","first-page":"92","article-title":"Neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy for dengue vaccine","author":"Tsai","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tim.2015.12.004","article-title":"The interplay of dengue virus morphological diversity and human antibodies","volume":"24","author":"Lok","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.virol.2016.06.022","article-title":"Enhancing dengue virus maturation using a stable furin over-expressing cell line","volume":"497","author":"Mukherjee","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.05.012_b0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni0715-785a","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0145","first-page":"351","article-title":"Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue-exposed individuals","volume":"215","author":"Henein","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.012_b0150","doi-asserted-by":"crossref","first-page":"16164","DOI":"10.1038\/nmicrobiol.2016.164","article-title":"Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity","volume":"19","author":"Chan","year":"2016","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2019.05.012_b0155","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.05.012_b0160","doi-asserted-by":"crossref","first-page":"e0003564","DOI":"10.1371\/journal.pntd.0003564","article-title":"Antibodies against immature virions are not a discriminating factor for dengue disease severity","volume":"11;9(3)","author":"Rodenhuis-Zybert","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"10.1016\/j.vaccine.2019.05.012_b0165","doi-asserted-by":"crossref","first-page":"ofv172","DOI":"10.1093\/ofid\/ofv172","article-title":"Influence of FcgammaRIIa-Expressing cells on the assessment of neutralizing and enhancing serum antibodies elicited by a live-attenuated tetravalent dengue vaccine","volume":"2","author":"Byers","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2019.05.012_b0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jviromet.2008.03.026","article-title":"Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines","volume":"151","author":"Mantel","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2019.05.012_b0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5012\/bkcs.2011.32.2.599","article-title":"Pressure cycling technology-assisted protein digestion for efficient proteomic analysis","volume":"32","author":"Choi","year":"2011","journal-title":"Bull Korean Chem Soc"},{"key":"10.1016\/j.vaccine.2019.05.012_b0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ab.2013.03.023","article-title":"Pressure-assisted sample preparation for proteomic analysis","volume":"438","author":"Olszowy","year":"2013","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2019.05.012_b0185","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","article-title":"Skyline: an open source document editor for creating and analyzing targeted proteomics experiments","volume":"26","author":"MacLean","year":"2010","journal-title":"Bioinformatics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19306243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:33:37Z","timestamp":1759401217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19306243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":37,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0264410X19306243"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complementary use of mass spectrometry and cryo-electron microscopy to assess the maturity of live attenuated dengue vaccine viruses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}